Crispr: is it a good idea to ‘upgrade’ our DNA?

Last year Tony Perry made mice that would have been brown-furred grow up white instead. That Perry, a molecular embryologist at the University of Bath, tweaked their coat colour isn’t new – scientists have been making so-called knock-out mice, in which certain genes are disabled,...
Read More

CRISPR Gets Lit Up and Tuned

By now, most within the biomedical fields have likely at least heard mention of the gene-editing tool known as CRISPR/Cas9. Since 2013, this technique has created a veritable revolution within the disciplines of molecular biology and genetics and is already showing tremendous promise for treating...
Read More

A CRISPR Look at Genome Editing

New Tools Are Driving Science even Further Ahead with the Ability to Interrogate the Function of any DNA Sequence in almost any Animal Model Andrea Toell, Ph.D. Genome editing techniques have taken a giant leap forwards since the development of recombinant DNA technology back in...
Read More

Could CRISPR be the Magic Bullet?

You Can Be “On Target” and Still Fail to Win a Prize. MaryAnn Labant. Research scientists and tool suppliers in the life sciences continue to devote resources to CRISPR, which is still a relatively new tool. Much is still unknown, and the community needs a deeper...
Read More

CRISPR germline editing reverberates through biotech community

The organizers of a recent meeting in Napa, California, to consider the broad societal implications of clustered, regularly interspaced, short palindromic repeats (CRISPR) genome editing have succeeded in their primary goal of stimulating public debate on the ethical issues raised by the technology. Although the...
Read More

7 Gene Editing Companies Investors Should Watch

7 Gene Editing Companies Investors Should Watch – Nanalyze A gene editing technology called CRISPR has been called “The Biggest Biotech Discovery of the Century” by the MIT Technology Review and Forbes magazine has said that this technology could change biotech forever. Some surprising news came...
Read More

HOW WAS IT DONE?

The team tried to tweak the gene responsible for ß-thalassaemia, a potentially deadly blood disorder, using a germ line editing technique known as CRISPR/Cas9. CRISPR technology precisely changes target parts of genetic code. Unlike other gene-silencing tools, the CRISPR system targets the genome’s source material...
Read More